Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma. Review uri icon

Overview

abstract

  • Diabetes and obesity are associated with nonalcoholic fatty liver disease (NAFLD) and an increased incidence of hepatocellular carcinoma (HCC). NAFLD is the commonest cause of chronic liver disease. HCC can develop in NAFLD patients even without cirrhosis, suggesting an association between the metabolic process and HCC and raising a concern that many cancers could be missed given high NAFLD prevalence and screening limitations. The increasing prevalence of these conditions and lack of effective treatments necessitate a better understanding of their connection. This article defines the known interrelationships and common pathways between NAFLD, diabetes, obesity and HCC and possible chemoprevention strategies.

publication date

  • March 12, 2015

Research

keywords

  • Carcinoma, Hepatocellular
  • Diabetes Mellitus, Type 2
  • Liver Neoplasms
  • Non-alcoholic Fatty Liver Disease
  • Obesity

Identity

PubMed Central ID

  • PMC6658171

Scopus Document Identifier

  • 84928825488

Digital Object Identifier (DOI)

  • 10.1016/j.cld.2015.01.012

PubMed ID

  • 25921668

Additional Document Info

volume

  • 19

issue

  • 2